Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederbayer.com
Bayer Corporate News
Get the latest updates from Bayer Corporate News directly as they happen.
Follow now 104 followers
Latest posts
Last updated over 1 year ago
“Bayer has excellent prospects for the future”
about 2 years ago
Leverkusen, April 28, 2023 – Bayer strengthened its position as a successful...
New data from pivotal studies with aflibercept 8 mg
about 2 years ago
Berlin, April 17, 2023 – Bayer and its collaborator Regeneron will present...
Bayer to present latest research across its advancing oncology portfolio at AACR 2023 Annual Meeting
about 2 years ago
Abstracts: ND04, 5047, CT276, 2116, 4035, 433, CT126, 1964, 925, CT228, 311...
Bayer to invest a total of 60 million euros in its Ukrainian seed production site
about 2 years ago
Leverkusen/Kyiv, April 5, 2023 – Bayer has revealed an investment of overall...
Bayer expands global clinical program for darolutamide in prostate cancer
about 2 years ago
Berlin, March 23, 2023 – Bayer further expands the global clinical development...
Bayer pledges to help tackle global water crisis with new water strategy
about 2 years ago
Leverkusen, March 21, 2023 – Bayer is launching its new water strategy...
Bayer collaborates with Microsoft to unveil new cloud-based enterprise solutions, advancing innovation and transparency in the agri-food industry
about 2 years ago
San Francisco / California, March 14, 2023 – Following a 2021 strategic...
Nubeqa™ (darolutamide) approved for additional prostate cancer indication in China
about 2 years ago
Berlin, March 20, 2023 – The Chinese National Medical Products Administration (NMPA)...
Bayer completes acquisition of Blackford Analysis Ltd.
about 2 years ago
Berlin, February 13, 2023 – Bayer today announced that the company has...
Bayer driving innovation in radiology with new research across the portfolio presented at ECR
about 2 years ago
Berlin, February 22, 2023 – Bayer announced today that new data from...
New data presented at ASCO GU confirm survival benefits and favorable safety profile of darolutamide across different subgroups of patients with metastatic hormone-sensitive prostate cancer
about 2 years ago
Berlin, February 16, 2023 – New subgroup data from the Phase III...
Aleksandra Rizo Appointed as CEO of Vividion Therapeutics
over 2 years ago
SAN DIEGO – January [24], 2023 – Vividion Therapeutics, Inc., (Vividion) a...